Poplar Forest Capital Has Decreased Abbott Labs (ABT) Stake; Mestek (MCC)’s Sentiment Is 1.38

November 14, 2017 - By Hazel Jackson

Medley Capital Corporation is a non-diversified closed-end management investment company. The company has market cap of $315.13 million. The Company’s investment objective is to generate current income

and capital appreciation by lending directly to privately-held middle market companies, primarily through directly originated transactions to help these companies expand their business, refinance and make acquisitions. It currently has negative earnings. The Company’s investment portfolio includes senior secured first lien term loans, senior secured second lien term loans, unitranche, senior secured first lien notes, subordinated notes and warrants and minority equity securities.

Poplar Forest Capital Llc decreased Abbott Labs (ABT) stake by 0.57% reported in 2017Q2 SEC filing. Poplar Forest Capital Llc sold 7,048 shares as Abbott Labs (ABT)’s stock declined 3.42%. The Poplar Forest Capital Llc holds 1.22M shares with $59.54 million value, down from 1.23 million last quarter. Abbott Labs now has $95.65 billion valuation. The stock declined 0.63% or $0.35 reaching $54.95 per share. About 2.67M shares traded. Abbott Laboratories (NYSE:ABT) has risen 15.90% since November 14, 2016 and is uptrending. It has underperformed by 0.80% the S&P500.

Poplar Forest Capital Llc increased Signet Jewelers Limited (NYSE:SIG) stake by 88,635 shares to 804,036 valued at $50.85M in 2017Q2. It also upped Perrigo Co Plc (NYSE:PRGO) stake by 7,190 shares and now owns 14,790 shares. Johnson Ctls Intl Plc was raised too.

Among 24 analysts covering Abbott Laboratories (NYSE:ABT), 14 have Buy rating, 0 Sell and 10 Hold. Therefore 58% are positive. Abbott Laboratories had 87 analyst reports since July 24, 2015 according to SRatingsIntel. Argus Research upgraded the stock to “Buy” rating in Friday, February 5 report. The stock of Abbott Laboratories (NYSE:ABT) has “Outperform” rating given on Friday, January 29 by RBC Capital Markets. The stock of Abbott Laboratories (NYSE:ABT) earned “Buy” rating by RBC Capital Markets on Monday, June 26. The company was maintained on Thursday, October 19 by Stifel Nicolaus. On Thursday, September 28 the stock rating was maintained by Barclays Capital with “Overweight”. The firm has “Equal-Weight” rating given on Thursday, October 19 by Morgan Stanley. The stock of Abbott Laboratories (NYSE:ABT) has “Market Perform” rating given on Tuesday, March 14 by BMO Capital Markets. The firm earned “Buy” rating on Friday, July 21 by Deutsche Bank. RBC Capital Markets maintained it with “Buy” rating and $55.0 target in Monday, October 2 report. The rating was maintained by Jefferies with “Buy” on Tuesday, September 13.

Investors sentiment decreased to 0.88 in 2017 Q2. Its down 0.75, from 1.63 in 2017Q1. It dived, as 69 investors sold ABT shares while 545 reduced holdings. 102 funds opened positions while 441 raised stakes. 1.22 billion shares or 0.83% more from 1.21 billion shares in 2017Q1 were reported. Farmers And Merchants Invests stated it has 0.48% in Abbott Laboratories (NYSE:ABT). Employees Retirement Sys Of Texas holds 94,062 shares or 0.06% of its portfolio. 11,226 are held by New England Private Wealth Advisors Ltd Company. Tokio Marine Asset Mngmt has 0.13% invested in Abbott Laboratories (NYSE:ABT). King Wealth Management Limited Liability Co invested in 9,353 shares or 0.18% of the stock. Perella Weinberg Prtn Lp owns 60,914 shares or 0.36% of their US portfolio. Parkside Bank & Trust & holds 0.28% of its portfolio in Abbott Laboratories (NYSE:ABT) for 13,886 shares. Plancorp Limited Company has invested 0.36% in Abbott Laboratories (NYSE:ABT). Cambridge Inv Advsrs invested 0.13% of its portfolio in Abbott Laboratories (NYSE:ABT). Pettyjohn Wood And White has 67,351 shares for 1.21% of their portfolio. Shufro Rose And Limited Liability Corp reported 7,200 shares stake. Mason Street Advisors Llc accumulated 0.29% or 240,837 shares. 134,749 are held by Northeast Mgmt. Pictet And Cie (Europe) Sa has 57,328 shares for 0.39% of their portfolio. Brandywine Trust Co owns 165,405 shares.

Since June 15, 2017, it had 0 insider buys, and 1 sale for $26,482 activity. 552 shares valued at $26,482 were sold by Watkin Jared on Thursday, June 15.

Analysts await Abbott Laboratories (NYSE:ABT) to report earnings on January, 24. They expect $0.73 earnings per share, up 12.31% or $0.08 from last year’s $0.65 per share. ABT’s profit will be $1.27B for 18.82 P/E if the $0.73 EPS becomes a reality. After $0.66 actual earnings per share reported by Abbott Laboratories for the previous quarter, Wall Street now forecasts 10.61% EPS growth.

Analysts await Medley Capital Corp (NYSE:MCC) to report earnings on December, 7 before the open. They expect $0.15 EPS, down 34.78% or $0.08 from last year’s $0.23 per share. MCC’s profit will be $8.18M for 9.63 P/E if the $0.15 EPS becomes a reality. After $0.18 actual EPS reported by Medley Capital Corp for the previous quarter, Wall Street now forecasts -16.67% negative EPS growth.

American Financial Group Inc holds 1.34% of its portfolio in Medley Capital Corp for 2.20 million shares. Cue Financial Group Inc. owns 209,900 shares or 0.96% of their US portfolio. Moreover, Selway Asset Management has 0.56% invested in the company for 152,855 shares. The Illinois-based West Family Investments Inc. has invested 0.52% in the stock. Arete Wealth Advisors Llc, a Illinois-based fund reported 134,270 shares.

By

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>